Consulting Services
Compare Stocks
5 / 10Stock Comparison
VRSK vs MSCI vs MCO vs SPGI vs FDS
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
VRSK vs MSCI vs MCO vs SPGI vs FDS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Consulting Services | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges |
| Market Cap | $22.89B | $42.83B | $81.04B | $126.89B | $9.63B |
| Revenue (TTM) | $3.10B | $3.13B | $7.72B | $15.34B | $2.32B |
| Net Income (TTM) | $910M | $1.32B | $2.50B | $4.78B | $600M |
| Gross Margin | 67.4% | 82.4% | 68.2% | 70.2% | 52.7% |
| Operating Margin | 44.9% | 54.7% | 44.8% | 42.2% | 32.2% |
| Forward P/E | 22.9x | 30.0x | 27.4x | 21.8x | 12.6x |
| Total Debt | $5.04B | $6.31B | $7.35B | $14.20B | $1.56B |
| Cash & Equiv. | $2.18B | $515M | $2.38B | $1.75B | $338M |
VRSK vs MSCI vs MCO vs SPGI vs FDS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Verisk Analytics, I… (VRSK) | 100 | 101.2 | +1.2% |
| MSCI Inc. (MSCI) | 100 | 178.9 | +78.9% |
| Moody's Corporation (MCO) | 100 | 170.9 | +70.9% |
| S&P Global Inc. (SPGI) | 100 | 131.9 | +31.9% |
| FactSet Research Sy… (FDS) | 100 | 72.8 | -27.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRSK vs MSCI vs MCO vs SPGI vs FDS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRSK plays a supporting role in this comparison — it may shine differently against other peers.
MSCI carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 7.2% 10Y total return vs MCO's 409.5%
- 9.7% NII/revenue growth vs FDS's 5.4%
- 38.4% margin vs FDS's 25.7%
- +7.8% vs FDS's -48.1%
MCO is the clearest fit if your priority is growth exposure.
- Rev growth 8.9%, EPS growth 21.4%
Among these 5 stocks, SPGI doesn't own a clear edge in any measured category.
FDS is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 21 yrs, beta 0.43, yield 1.9%
- Lower volatility, beta 0.43, Low D/E 71.3%, current ratio 1.40x
- PEG 1.26 vs MCO's 3.51
- Beta 0.43, yield 1.9%, current ratio 1.40x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% NII/revenue growth vs FDS's 5.4% | |
| Value | Lower P/E (12.6x vs 27.4x), PEG 1.26 vs 3.51 | |
| Quality / Margins | 38.4% margin vs FDS's 25.7% | |
| Stability / Safety | Beta 0.43 vs MCO's 0.86, lower leverage | |
| Dividends | 1.9% yield, 21-year raise streak, vs MCO's 0.9% | |
| Momentum (1Y) | +7.8% vs FDS's -48.1% | |
| Efficiency (ROA) | 24.0% ROA vs SPGI's 7.9%, ROIC 34.9% vs 9.7% |
VRSK vs MSCI vs MCO vs SPGI vs FDS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VRSK vs MSCI vs MCO vs SPGI vs FDS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSCI leads in 2 of 6 categories
FDS leads 1 • VRSK leads 0 • MCO leads 0 • SPGI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSCI leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
SPGI is the larger business by revenue, generating $15.3B annually — 6.6x FDS's $2.3B. MSCI is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to FDS's 25.7%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.1B | $3.1B | $7.7B | $15.3B | $2.3B |
| EBITDAEarnings before interest/tax | $1.7B | $2.0B | $4.0B | $7.8B | $947M |
| Net IncomeAfter-tax profit | $910M | $1.3B | $2.5B | $4.8B | $600M |
| Free Cash FlowCash after capex | $1.1B | $1.5B | $3.0B | $5.6B | $647M |
| Gross MarginGross profit ÷ Revenue | +67.4% | +82.4% | +68.2% | +70.2% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +44.9% | +54.7% | +44.8% | +42.2% | +32.2% |
| Net MarginNet income ÷ Revenue | +29.3% | +38.4% | +31.9% | +29.2% | +25.7% |
| FCF MarginFCF ÷ Revenue | +36.3% | +49.4% | +33.4% | +35.6% | +26.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.9% | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +4.8% | +49.1% | +7.8% | +32.5% | +4.4% |
Valuation Metrics
FDS leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 14.4x trailing earnings, FDS trades at a 62% valuation discount to MSCI's 37.8x P/E. Adjusting for growth (PEG ratio), FDS offers better value at 1.44x vs MCO's 4.29x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $22.9B | $42.8B | $81.0B | $126.9B | $9.6B |
| Enterprise ValueMkt cap + debt − cash | $25.7B | $48.6B | $86.0B | $139.3B | $10.9B |
| Trailing P/EPrice ÷ TTM EPS | 26.92x | 37.81x | 33.44x | 29.24x | 14.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.85x | 29.99x | 27.37x | 21.84x | 12.62x |
| PEG RatioP/E ÷ EPS growth rate | 3.16x | 2.23x | 4.29x | 3.36x | 1.44x |
| EV / EBITDAEnterprise value multiple | 15.34x | 25.17x | 21.86x | 18.20x | 11.59x |
| Price / SalesMarket cap ÷ Revenue | 7.45x | 13.67x | 10.50x | 8.27x | 4.15x |
| Price / BookPrice ÷ Book value/share | 78.44x | — | 19.56x | 3.62x | 3.93x |
| Price / FCFMarket cap ÷ FCF | 19.20x | 27.65x | 31.47x | 23.26x | 15.60x |
Profitability & Efficiency
MSCI leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
VRSK delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $13 for SPGI. SPGI carries lower financial leverage with a 0.39x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRSK's 16.26x. On the Piotroski fundamental quality scale (0–9), MCO scores 9/9 vs VRSK's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.4% | — | +64.1% | +12.9% | +27.7% |
| ROA (TTM)Return on assets | +16.7% | +24.0% | +16.2% | +7.9% | +14.2% |
| ROICReturn on invested capital | +33.0% | +34.9% | +22.5% | +9.7% | +15.5% |
| ROCEReturn on capital employed | +39.6% | +44.3% | +27.9% | +12.1% | +20.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 | 9 | 7 | 7 |
| Debt / EquityFinancial leverage | 16.26x | — | 1.75x | 0.39x | 0.71x |
| Net DebtTotal debt minus cash | $2.9B | $5.8B | $5.0B | $12.5B | $1.2B |
| Cash & Equiv.Liquid assets | $2.2B | $515M | $2.4B | $1.7B | $338M |
| Total DebtShort + long-term debt | $5.0B | $6.3B | $7.4B | $14.2B | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 7.87x | 7.67x | 17.22x | 22.69x | 14.22x |
Total Returns (Dividends Reinvested)
Evenly matched — MSCI and MCO each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCO five years ago would be worth $14,141 today (with dividends reinvested), compared to $7,219 for FDS. Over the past 12 months, MSCI leads with a +7.8% total return vs FDS's -48.1%. The 3-year compound annual growth rate (CAGR) favors MCO at 15.2% vs FDS's -16.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -20.7% | +4.5% | -8.2% | -16.2% | -21.0% |
| 1-Year ReturnPast 12 months | -43.0% | +7.8% | -1.5% | -14.5% | -48.1% |
| 3-Year ReturnCumulative with dividends | -14.5% | +28.6% | +52.8% | +23.8% | -41.3% |
| 5-Year ReturnCumulative with dividends | +1.8% | +27.9% | +41.4% | +14.2% | -27.8% |
| 10-Year ReturnCumulative with dividends | +137.1% | +720.9% | +409.5% | +337.1% | +68.6% |
| CAGR (3Y)Annualised 3-year return | -5.1% | +8.7% | +15.2% | +7.4% | -16.3% |
Risk & Volatility
Evenly matched — VRSK and MSCI each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRSK is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than MCO's 0.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MSCI currently trades 93.9% from its 52-week high vs FDS's 47.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.04x | 0.61x | 0.86x | 0.58x | 0.43x |
| 52-Week HighHighest price in past year | $322.92 | $626.28 | $546.88 | $579.05 | $474.79 |
| 52-Week LowLowest price in past year | $161.70 | $501.08 | $402.28 | $381.61 | $189.07 |
| % of 52W HighCurrent price vs 52-week peak | +54.1% | +93.9% | +83.6% | +74.0% | +47.2% |
| RSI (14)Momentum oscillator 0–100 | 39.5 | 54.6 | 48.0 | 42.4 | 39.7 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 520K | 1.1M | 1.8M | 908K |
Analyst Outlook
Evenly matched — MCO and FDS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VRSK as "Hold", MSCI as "Buy", MCO as "Buy", SPGI as "Buy", FDS as "Hold". Consensus price targets imply 32.4% upside for VRSK (target: $231) vs 14.6% for MSCI (target: $674). For income investors, FDS offers the higher dividend yield at 1.86% vs MCO's 0.85%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $231.25 | $674.33 | $544.75 | $548.11 | $277.89 |
| # AnalystsCovering analysts | 25 | 27 | 32 | 28 | 28 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | +1.2% | +0.9% | +0.9% | +1.9% |
| Dividend StreakConsecutive years of raises | 7 | 11 | 22 | 12 | 21 |
| Dividend / ShareAnnual DPS | $1.81 | $7.20 | $3.90 | $3.83 | $4.17 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.7% | +5.8% | +2.1% | +3.9% | +3.1% |
MSCI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FDS leads in 1 (Valuation Metrics). 3 tied.
VRSK vs MSCI vs MCO vs SPGI vs FDS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VRSK or MSCI or MCO or SPGI or FDS a better buy right now?
For growth investors, MSCI Inc.
(MSCI) is the stronger pick with 9. 7% revenue growth year-over-year, versus 5. 4% for FactSet Research Systems Inc. (FDS). FactSet Research Systems Inc. (FDS) offers the better valuation at 14. 4x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate MSCI Inc. (MSCI) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRSK or MSCI or MCO or SPGI or FDS?
On trailing P/E, FactSet Research Systems Inc.
(FDS) is the cheapest at 14. 4x versus MSCI Inc. at 37. 8x. On forward P/E, FactSet Research Systems Inc. is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: FactSet Research Systems Inc. wins at 1. 26x versus Moody's Corporation's 3. 51x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — VRSK or MSCI or MCO or SPGI or FDS?
Over the past 5 years, Moody's Corporation (MCO) delivered a total return of +41.
4%, compared to -27. 8% for FactSet Research Systems Inc. (FDS). Over 10 years, the gap is even starker: MSCI returned +720. 9% versus FDS's +68. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRSK or MSCI or MCO or SPGI or FDS?
By beta (market sensitivity over 5 years), Verisk Analytics, Inc.
(VRSK) is the lower-risk stock at -0. 04β versus Moody's Corporation's 0. 86β — meaning MCO is approximately -2508% more volatile than VRSK relative to the S&P 500. On balance sheet safety, S&P Global Inc. (SPGI) carries a lower debt/equity ratio of 39% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRSK or MSCI or MCO or SPGI or FDS?
By revenue growth (latest reported year), MSCI Inc.
(MSCI) is pulling ahead at 9. 7% versus 5. 4% for FactSet Research Systems Inc. (FDS). On earnings-per-share growth, the picture is similar: Moody's Corporation grew EPS 21. 4% year-over-year, compared to -3. 3% for Verisk Analytics, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRSK or MSCI or MCO or SPGI or FDS?
MSCI Inc.
(MSCI) is the more profitable company, earning 38. 4% net margin versus 25. 7% for FactSet Research Systems Inc. — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSCI leads at 54. 7% versus 32. 2% for FDS. At the gross margin level — before operating expenses — MSCI leads at 82. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRSK or MSCI or MCO or SPGI or FDS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, FactSet Research Systems Inc. (FDS) is the more undervalued stock at a PEG of 1. 26x versus Moody's Corporation's 3. 51x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, FactSet Research Systems Inc. (FDS) trades at 12. 6x forward P/E versus 30. 0x for MSCI Inc. — 17. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRSK: 32. 4% to $231. 25.
08Which pays a better dividend — VRSK or MSCI or MCO or SPGI or FDS?
All stocks in this comparison pay dividends.
FactSet Research Systems Inc. (FDS) offers the highest yield at 1. 9%, versus 0. 9% for Moody's Corporation (MCO).
09Is VRSK or MSCI or MCO or SPGI or FDS better for a retirement portfolio?
For long-horizon retirement investors, Verisk Analytics, Inc.
(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), 1. 0% yield, +137. 1% 10Y return). Both have compounded well over 10 years (VRSK: +137. 1%, MCO: +409. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRSK and MSCI and MCO and SPGI and FDS?
These companies operate in different sectors (VRSK (Industrials) and MSCI (Financial Services) and MCO (Financial Services) and SPGI (Financial Services) and FDS (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VRSK is a mid-cap quality compounder stock; MSCI is a mid-cap quality compounder stock; MCO is a mid-cap quality compounder stock; SPGI is a mid-cap quality compounder stock; FDS is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.